Audra Boscoe

1.3k total citations
29 papers, 955 citations indexed

About

Audra Boscoe is a scholar working on Physiology, Genetics and Hematology. According to data from OpenAlex, Audra Boscoe has authored 29 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 9 papers in Genetics and 7 papers in Hematology. Recurrent topics in Audra Boscoe's work include Erythrocyte Function and Pathophysiology (10 papers), Blood disorders and treatments (6 papers) and Multiple Sclerosis Research Studies (4 papers). Audra Boscoe is often cited by papers focused on Erythrocyte Function and Pathophysiology (10 papers), Blood disorders and treatments (6 papers) and Multiple Sclerosis Research Studies (4 papers). Audra Boscoe collaborates with scholars based in United States, United Kingdom and Canada. Audra Boscoe's co-authors include Catherine Rolland, Robin Kate Kelley, Joseph G. Verbalis, Clark Paramore, Karin S. Coyne, Adrianne C. Feldstein, Rami Ben‐Joseph, Marsha A. Raebel, Paul Fishman and David J. Magid and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and Neurology.

In The Last Decade

Audra Boscoe

26 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Audra Boscoe United States 14 213 197 172 154 148 29 955
Fan Mu United States 21 225 1.1× 83 0.4× 274 1.6× 125 0.8× 59 0.4× 91 1.6k
Akiko Kada Japan 16 185 0.9× 92 0.5× 224 1.3× 291 1.9× 87 0.6× 86 866
Adem Küçük Türkiye 18 181 0.8× 93 0.5× 81 0.5× 86 0.6× 53 0.4× 79 1.0k
Peter Wiesli Switzerland 18 230 1.1× 121 0.6× 132 0.8× 185 1.2× 59 0.4× 61 1.4k
Maria Kohl Austria 17 84 0.4× 78 0.4× 108 0.6× 118 0.8× 76 0.5× 30 709
Huei‐Kai Huang Taiwan 18 167 0.8× 64 0.3× 61 0.4× 143 0.9× 50 0.3× 67 892
Bülent Canbaz Türkiye 16 274 1.3× 129 0.7× 60 0.3× 88 0.6× 45 0.3× 46 1.1k
Hiroaki Tanaka Japan 22 195 0.9× 47 0.2× 190 1.1× 359 2.3× 68 0.5× 133 1.4k
Christine Iannaccone United States 23 99 0.5× 69 0.4× 356 2.1× 96 0.6× 244 1.6× 62 1.8k
Carlos Cantú‐Brito Mexico 20 108 0.5× 409 2.1× 190 1.1× 187 1.2× 45 0.3× 121 1.2k

Countries citing papers authored by Audra Boscoe

Since Specialization
Citations

This map shows the geographic impact of Audra Boscoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audra Boscoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audra Boscoe more than expected).

Fields of papers citing papers by Audra Boscoe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audra Boscoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audra Boscoe. The network helps show where Audra Boscoe may publish in the future.

Co-authorship network of co-authors of Audra Boscoe

This figure shows the co-authorship network connecting the top 25 collaborators of Audra Boscoe. A scholar is included among the top collaborators of Audra Boscoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audra Boscoe. Audra Boscoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boscoe, Audra, et al.. (2024). Reporting on Therapeutic Advancements Requires Accurate Language. American Journal of Therapeutics. 32(1). e48–e49.
2.
Andrae, David, Rachael F. Grace, Robert J. Klaassen, et al.. (2023). Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial. Journal of Patient-Reported Outcomes. 7(1). 112–112.
3.
Zagadailov, Erin, Hanny Al‐Samkari, Audra Boscoe, et al.. (2023). Mortality among US veterans with a physician-documented diagnosis of pyruvate kinase deficiency. Hematology. 29(1). 2290746–2290746.
4.
Grace, Rachael F., Eduard J. van Beers, Joan‐Lluís Vives Corrons, et al.. (2023). The Pyruvate Kinase Deficiency Global Longitudinal (Peak) Registry: rationale and study design. BMJ Open. 13(3). e063605–e063605. 3 indexed citations
5.
Chamberlain, Christina X., Elizabeth Faust, Nathan A. S. Webster, et al.. (2021). Burden of illness for patients with cholangiocarcinoma in the United States: a retrospective claims analysis. Journal of Gastrointestinal Oncology. 12(2). 658–668. 9 indexed citations
6.
Zagadailov, Erin, et al.. (2021). Validation of the Pyruvate Kinase Deficiency Diary (PKDD): A Patient-Reported Outcome Measure for Pyruvate Kinase (PK) Deficiency. Blood. 138(Supplement 1). 4144–4144. 3 indexed citations
7.
Boscoe, Audra, Elizabeth Hedgeman, Eduard J. van Beers, et al.. (2020). Comorbidities and complications in adults with pyruvate kinase deficiency. European Journal Of Haematology. 106(4). 484–492. 17 indexed citations
8.
Zagadailov, Erin, Audra Boscoe, Sherry Shi, et al.. (2020). Mortality Among Veterans with a Diagnosis of Pyruvate Kinase (PK) Deficiency: A Real-World Study Using US Veterans Health Administration Data. Blood. 136(Supplement 1). 24–25. 1 indexed citations
9.
Boscoe, Audra, Catherine Rolland, & Robin Kate Kelley. (2019). Frequency and prognostic significance of isocitrate dehydrogenase 1 mutations in cholangiocarcinoma: a systematic literature review. Journal of Gastrointestinal Oncology. 10(4). 751–765. 127 indexed citations
10.
Secrest, Matthew H., et al.. (2019). Prevalence of Red Cell Pyruvate Kinase Deficiency: A Systematic Literature Review. Blood. 134(Supplement_1). 3513–3513. 1 indexed citations
11.
Incerti, Devin, Nicholas Summers, Thanh G.N. Ton, et al.. (2018). The Lifetime Health Burden of Delayed Graft Function in Kidney Transplant Recipients in the United States. MDM Policy & Practice. 3(1). 3442430323–3442430323. 22 indexed citations
12.
Ajmera, Mayank, Audra Boscoe, Josephine Mauskopf, Sean D. Candrilli, & Michael Levy. (2017). Evaluation of comorbidities and health care resource use among patients with highly active neuromyelitis optica. Journal of the Neurological Sciences. 384. 96–103. 40 indexed citations
13.
14.
Coyne, Karin S., et al.. (2015). Understanding Drivers of Employment Changes in a Multiple Sclerosis Population. International Journal of MS Care. 17(5). 245–252. 49 indexed citations
15.
Boudreau, Denise M., Daniel C. Malone, Marsha A. Raebel, et al.. (2009). Health Care Utilization and Costs by Metabolic Syndrome Risk Factors. Metabolic Syndrome and Related Disorders. 7(4). 305–314. 166 indexed citations
16.
Malone, Dan, Denise M. Boudreau, Marsha A. Raebel, et al.. (2009). Association of Cardiometabolic Risk Factors and Prevalent Cardiovascular Events. Metabolic Syndrome and Related Disorders. 7(6). 585–594. 9 indexed citations
17.
Beaton, Sarah J., Scott B. Robinson, Ann Von Worley, et al.. (2009). Cardiometabolic Risk and Health Care Utilization and Cost for Hispanic and Non-Hispanic Women. Population Health Management. 12(4). 177–183. 4 indexed citations
18.
Luce, Bryan R., Kristin L. Nichol, Robert B. Belshe, et al.. (2008). Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24–59 months in the United States. Vaccine. 26(23). 2841–2848. 53 indexed citations
19.
Boscoe, Audra, Clark Paramore, & Joseph G. Verbalis. (2006). Cost of illness of hyponatremia in the United States. Cost Effectiveness and Resource Allocation. 4(1). 10–10. 119 indexed citations
20.
Feldman, Arthur M., Gregory de Lissovoy, Michael R. Bristow, et al.. (2005). Cost Effectiveness of Cardiac Resynchronization Therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Journal of the American College of Cardiology. 46(12). 2311–2321. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fan Mu Breakdown of academic impact, for papers by Akiko Kada Breakdown of academic impact, for papers by Adem Küçük Breakdown of academic impact, for papers by Peter Wiesli Breakdown of academic impact, for papers by Maria Kohl Breakdown of academic impact, for papers by Huei‐Kai Huang Breakdown of academic impact, for papers by Bülent Canbaz Breakdown of academic impact, for papers by Hiroaki Tanaka Breakdown of academic impact, for papers by Christine Iannaccone Breakdown of academic impact, for papers by Carlos Cantú‐Brito
Rankless by CCL
2026